The carotid atherosclerotic plaque and microembolisation during carotid stenting

Journal of Cardiovascular Surgery

Volumn 47, Issue 2, 2006, Pages 115-126

  Hellings, W E ^a   Ackerstaff, R G A ^b   Pasterkamp, G ^a   de Vries, J P P M ^b   Moll, F L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Atherosclerosis; Carotid artery; Embolisation; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ARTIFICIAL EMBOLISM; ATHEROSCLEROTIC PLAQUE; BRAIN EMBOLISM; CAROTID ARTERY OBSTRUCTION; DEVICE; DOPPLER ECHOGRAPHY; ENDOVASCULAR SURGERY; FILTER; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; ISCHEMIA; MICROEMBOLISM; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PROTECTIVE EQUIPMENT; REVIEW; RISK FACTOR; STENT; SURGICAL TECHNIQUE;

ANGIOPLASTY; CAROTID ARTERY DISEASES; HUMANS; INTRACRANIAL EMBOLISM; RISK FACTORS; STENTS;

EID: 33646254403     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Featherstone RL, Brown MM, Coward LJ. International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis 2004;18:69-74.
2. Hobson RW, Howard VJ, Roubin GS, Brott TG, Ferguson RD, Popma JJ, Graham DL, Howard G. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004;40:1106-11.
3. Ringleb PA, Kunze A, Allenberg JR, Hennerici MG, Jansen O, Maurer PC et al. The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs Endarterectomy Trial. Cerebrovasc Dis 2004;18:66-8.
4. Endarterectomy vs Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial. Cerebrovasc Dis 2004;18:62-5.
5. Markus H. Monitoring embolism in real time. Circulation 2000;102:826-8.
6. Basic identification criteria of Doppler microembolic signals. Consensus Committee of the Ninth international Cerebral Hemodynamic Symposium. Stroke 1995;26:1123.
7. Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke 1998;29:725-9.
8. Markus H, Loh A, Israel D, Buckenham T, Clifton A, Brown MM. Microscopic air embolism during cerebral angiography and strategies for its avoidance. Lancet 1993;341:784-7.
9. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231-41.
10. Cosottini M, Michelassi MC, Puglioli M, Lazzarotti G, Orlandi G, Marconi F et al. Silent cerebral ischemia detected with diffusion-weighted imaging in patients treated with protected and unprotected carotid artery stenting. Stroke 2005;36:2389-93.
11. Hammer FD, Lacroix V, Duprez T, Grandin C, Verhelst R, Peeters A et al. Cerebral microembolization after protected carotid artery stenting in surgical high-risk patients: results of a 2-year prospective study. J Vasc Surg 2005;42:847-53.
12. Krapf H, Nagele T, Kastrup A, Buhring U, Gronewaller E, Skalej M et al. Risk factors for periprocedural complications in carotid artery stenting without filter protection A serial diffusion-weighted MRI study. J Neurol 2005 October 1.
13. Roh HG, Byun HS, Ryoo JW, Na DG, Moon WJ, Lee BB et al. Prospective analysis of cerebral infarction after carotid endarterectomy and carotid artery stent placement by using diffusion-weighted imaging. AJNR Am J Neuroradiol 2005;26:376-84.
14. Flach HZ, Ouhlous M, Hendriks JM, Van Sambeek MR, Veenland JF, Koudstaal PJ et al. Cerebral ischemia after carotid intervention. J Endovasc Ther 2004;11:251-7.
15. Poppert H, Wolf O, Resch M, Theiss W, Schmidt-Thieme T, Graefin von EH et al. Differences in number, size and location of intracranial microembolic lesions after surgical versus endovascular treatment without protection device of carotid artery stenosis. J Neurol 2004;251:1198-203.
16. Schluter M, Tubler T, Steffens JC, Mathey DG, Schofer J. Focal ischemia of the brain after neuroprotected carotid artery stenting. J Am Coll Cardiol 2003;42:1007-13.
17. van Heesewijk HP, Vos JA, Louwerse ES, Van Den Berg JC, Overtoom TT, Ernst SM et al. New brain lesions at MR imaging after carotid angioplasty and stent placement. Radiology 2002;224: 361-5.
18. Jaeger HJ, Mathias KD, Hauth E, Drescher R, Gissler HM, Hennigs S et al. Cerebral ischemia detected with diffusion-weighted MR imaging after stent implantation in the carotid artery. AJNR Am J Neuroradiol 2002;23:200-7.
19. Orlandi G, Fanucchi S, Gallerini S, Sonnoli C, Cosottini M, Puglioli M et al. Impaired clearance of microemboli and cerebrovascular symptoms during carotid stenting procedures. Arch Neurol 2005;62:1208-11.
20. Ackerstaff RG, Suttorp MJ, Van Den Berg JC, Overtoom TT, Vos JA, Bal ET et al. Prediction of early cerebral outcome by transcranial Doppler monitoring in carotid bifurcation angioplasty and stenting. J Vasc Surg 2005;41:618-24.
21. Schmidt A, Diederich KW, Scheinert S, Braunlich S, Olenburger T, Biamino G et al. Effect of two different neuroprotection systems on microembolization during carotid artery stenting. J Am Coll Cardiol 2004;44:1966-9.
22. Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 2001;104:1999-2002.
23. Jordan WD, Jr., Voellinger DC, Doblar DD, Plyushcheva NP, Fisher WS, McDowell HA. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg 1999;7:33-8.
24. McCleary AJ, Nelson M, Dearden NM, Calvey TA, Gough MJ. Cerebral haemodynamics and embolization during carotid angioplasty in high-risk patients. Br J Surg 1998;85:771-4.
25. Aronow HD, Shishehbor M, Davis DA, Katzan IL, Bhatt DL, Bajzer CT et al. Leukocyte count predicts microembolic Doppler signals during carotid stenting: a link between inflammation and embolization. Stroke 2005;36:1910-4.
26. Ackerstaff RG, Moons KG, Vand V, Moll FL, Vermeulen FE, Algra A et al. Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke 2000;31:1817-23.
27. Claus SP, Louwerse ES, Mauser HW, van der MM, Moll FL, Mess WH et al. Temporary occlusion of middle cerebral artery by macroembolism in carotid surgery. Cerebrovasc Dis 1999;9:261-4.
28. Vermeer SE, Prins ND, den HT, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22.
29. Lehrner J, Willfort A, Mlekusch I, Guttmann G, Minar E, Ahmadi R et al. Neuropsychological outcome 6 months after unilateral carotid stenting. J Clin Exp Neuropsychol 2005;27:859-66.
30. Hauth EA, Jansen C, Drescher R, Schwartz M, Forsting M, Jaeger HJ et al. MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting. AJNR Am J Neuroradiol 2005;26:2336-41.
31. Mathur A, Roubin GS, Iyer SS, Piamsonboon C, Liu MW, Gomez CR et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998;97:1239-45.
32. Roubin GS, New G, Iyer SS, Vitek JJ, Al-Mubarak N, Liu MW et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001;103:532-7.
33. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111:2233-40.
34. Vos JA, Van Den Berg JC, Ernst SM, Suttorp MJ, Overtoom TT, Mauser HW et al. Carotid angioplasty and stent placement: comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology 2005;234:493-9.
35. Parodi JC. Effect of two different neuroprotection systems on microembolization during carotid artery stenting. J Am Coll Cardiol 2005;46:382.
36. Hayes PD, Payne DA, Evans NJ, Thompson MM, London NJ, Bell PR et al. The excess of strokes in female patients after CEA is due to their increased thromboembolic potential - analysis of 775 cases. Eur J Vasc Endovasc Surg 2003;26:665-9.
37. Horn J, Naylor AR, Laman DM, Chambers BR, Stork JL, Schroeder TV et al. Identification of patients at risk for ischemic cerebral complications after carotid endarterectomy with TCD monitoring. Eur J Vasc Endovasc Surg 2005;30:270-4.
38. Laman DM, Wieneke GH, van DH, van Huffelen AC. High embolic rate early after carotid endarterectomy is associated with early cerebrovascular complications, especially in women. J Vasc Surg 2002;36:278-84.
39. Levi CR, O'Malley HM, Fell G, Roberts AK, Hoare MC, Royle JP et al. Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High microembolic signal loads predict postoperative cerebral ischaemia. Brain 1997;120 (Pt 4): 621-9.
40. Markus HS, Clifton A, Buckenham T, Brown MM. Carotid angioplasty. Detection of embolic signals during and after the procedure. Stroke 1994;25:2403-6.
41. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-501.
42. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
43. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
44. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512-31.
45. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.
46. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-61.
47. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-25.
48. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
49. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004;292:1845-52.
50. Gronholdt ML, Nordestgaard BG, Wiebe BM, Wilhjelm JE, Sillesen H. Echolucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation 1998;97:34-40.
51. Polak JF, Shemanski L, O'Leary DH, Lefkowitz D, Price TR, Savage PJ et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 1998;208:649-54.
52. Mathiesen EB, Bonaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromso study. Circulation 2001;103:2171-5.
53. Gronholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001;104:68-73.
54. Cai J, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu B et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005;112:3437-44.
55. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005;25:234-9.
56. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000;102:959-64.
57. Clarke SE, Beletsky V, Hammond RR, Hegele RA, Rutt BK. Validation of automatically classified magnetic resonance images for carotid plaque compositional analysis. Stroke 2006;37:93-7.
58. Trivedi RA, King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004;35:1631-5.
59. Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med 2004;45:1898-907.
60. Davies JR, Rudd JF, Fryer TD, Weissberg PL. Targeting the vulnerable plaque: the evolving role of nuclear imaging. J Nucl Cardiol 2005;12:234-46.
61. Rudd JH, Davies JR, Weissberg PL. Imaging of atherosclerosis - can we predict plaque rupture? Trends Cardiovasc Med 2005;15:17-24.
62. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-9.
63. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111: 1551-5.
64. Verhoeven BA, de Vries JP, Pasterkamp G, Ackerstaff RG, Schoneveld AH, Velema E et al. Carotid atherosclerotic plaque characteristics are associated with microembolization during carotid endarterectomy and procedural outcome. Stroke 2005;36:1735-40.
65. Vainas T, Kurvers HA, Mess WH, de GR, Ezzahiri R, Tordoir JH et al. Chlamydia pneumoniae serology is associated with thrombosis-related but not with plaque-related microembolization during carotid endarterectomy. Stroke 2002;33:1249-54.
66. van Oostrom O, Velema E, Schoneveld AH, de Vries JP, de BP, Seldenrijk CA et al. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol 2005;14:126-34.
67. Verhoeven B, Hellings WE, Moll FL, de Vries JP, de Kleijn DP, de BP et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg 2005;42:1075-81.
68. Angelini A, Reimers B, Della BM, Sacca S, Pasquetto G, Cernetti C et al. Cerebral protection during carotid artery stenting: collection and histopathologic analysis of embolized debris. Stroke 2002;33:456-61.
69. Martin JB, Pache JC, Treggiari-Venzi M, Murphy KJ, Gailloud P, Puget E et al. Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke 2001;32:479-84.
70. Qureshi AI, Luft AR, Janardhan V, Suri MF, Sharma M, Lanzino G et al. Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. Stroke 2000;31:376-82.
71. Biasi GM, Sampaolo A, Mingazzini P, De AP, El-Barghouty N, Nicolaides AN. Computer analysis of ultrasonic plaque echolucency in identifying high risk carotid bifurcation lesions. Eur J Vasc Endovasc Surg 1999;17:476-9.
72. Ohki T, Marin ML, Lyon RT, Berdejo GL, Soundararajan K, Ohki M et al. Ex vivo human carotid artery bifurcation stenting: correlation of lesion characteristics with embolic potential. J Vasc Surg 1998;27:463-71.
73. Ohki T, Roubin GS, Veith FJ, Iyer SS, Brady E. Efficacy of a filter device in the prevention of embotic events during carotid angioplasty and stenting: An ex vivo analysis. J Vasc Surg 1999;30:1034-44.
74. Bicknell CD, Cowling MG, Clark MW, Delis KT, Jenkins MP, Hughes AD et al. Carotid angioplasty in a pulsatile flow model: factors affecting embolic potential. Eur J Vasc Endovasc Surg 2003;26: 22-31.
75. Rapp JH, Pan XM, Yu B, Swanson RA, Higashida RT, Simpson P, Saloner D. Cerebral ischemia and infarction from atheroemboli <100 microm in Size. Stroke 2003;34:1976-80.
76. Ridker PM. Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation. Curr Cardiol Rep 2000;2:269-73.
77. Libby P. Lipid-lowering therapy stabilizes plaque, reduces events by limiting inflammation. Am J Manag Care 2002;Suppl:1, 4.
78. Halcox JP, Deanfield JE. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation 2004 1;10921 (Suppl 1):II42-II48.
79. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001;103:926-33.
80. Muller-Hulsbeck S, Stolzmann P, Liess C, Hedderich J, Paulsen F, Jahnke T et al. Vessel wall damage caused by cerebral protection devices: ex vivo evaluation in porcine carotid arteries. Radiology 2005;235:454-60.
81. Schonholz CJ, Uflacker R, Mendaro E, Parodi JC, Guimaraes M, Hannegan C et al. Techniques for carotid artery stenting under cerebral protection. J Cardiovasc Surg (Torino) 2005;46:201-17.
82. Muller-Hulsbeck S, Husler EJ, Schaffner SR, Jahnke T, Glass C, Wenke R et al. An in vitro analysis of a carotid artery stent with a protective porous membrane. J Vasc Interv Radiol 2004;15:1295-305.
83. Cil BE, Akpinar E, Peynircioglu B, Cekirge S. Utility of covered stents for extracranial internal carotid artery stenosis. AJNR Am J Neuroradiol 2004;25:1168-71.
84. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9.
85. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
86. Hellings WE, Verhoeven BA, Moll FL, Koekkoek J, de Vries JP, Velema E et al. Statin use and plaque phenotype: a retrospective study in 378 patients undergoing carotid endarterectomy. J Vasc Res 2005;42(S2):113.
87. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999;30:1969-73.
88. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005;36:1298-300.
89. McGirt MJ, Perler BA, Brooke BS, Woodworth GF, Coon A, Jain S et al. -hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 2005;42:829-36.
90. Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 2005;36:2072-6.